Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy
- PMID: 21497925
- DOI: 10.1016/j.radonc.2011.03.006
Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy
Abstract
Background and purpose: Resection is considered as essential for the efficacy of modern adjuvant treatment of glioblastoma multiforme (GBM). Previous studies have indicated that amino acid PET is more specific than contrast enhancement on MRI for detecting residual tumor tissue after surgery. In a prospective study we investigated the prognostic impact of postoperative tumor volume and tumor/brain ratios (TBR) in PET using O-(2-[(18)F]fluoroethyl)-l-tyrosine (FET) in comparison with MRI.
Materials and methods: Forty-four patients with GBM were investigated by FET PET and MRI after surgery. Tumor volume in FET PET with a tumor/brain ratio (TBR)>1.6 and a TBR>2, mean and maximum TBR and gadolinium contrast-enhancement on MRI (Gd-volume) were determined. Thereafter patients received a fractionated radiotherapy with concomitant temozolomide (RCX). The median follow-up was 15.4 (3-35) months. The prognostic value of postoperative residual tumor volume in FET PET, TBR(mean,) TBR(max) and Gd-volume was evaluated using Kaplan-Maier estimates for disease-free survival (DFS) and overall survival (OS).
Results: Postoperative tumor volume in FET PET had a significant independent influence on OS and DFS (OS 20.0 vs. 6.9 months; DFS 9.6 vs. 5.1 months, p<0.001; cut-off 25 ml). Similar results were observed when a TBR ≥ 2 (cut-off 10 ml) was used to define the tumor volume in (18)F-FET PET. The TBR(mean) and TBR(max) of FET uptake had a significant influence on DFS (p<0.05). Gd-volume in MRI had significant effect on OS and DFS in the univariate analysis. No independent significant influence in OS or DFS could be observed for Gd-volume in MRI.
Conclusions: Our data indicate that the tumor volume in FET PET after surgery of GBM has a strong prognostic impact for these patients. FET PET appears to be helpful to determine the residual tumor volume after surgery of GBM and may serve as a valuable tool for optimal planning of radiation treatment.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.J Nucl Med. 2012 Jul;53(7):1048-57. doi: 10.2967/jnumed.111.098590. Epub 2012 May 29. J Nucl Med. 2012. PMID: 22645298
-
Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):176-84. doi: 10.1016/j.ijrobp.2010.01.055. Epub 2010 Jun 18. Int J Radiat Oncol Biol Phys. 2011. PMID: 20646863
-
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.Neurology. 2015 Feb 17;84(7):710-9. doi: 10.1212/WNL.0000000000001262. Epub 2015 Jan 21. Neurology. 2015. PMID: 25609769
-
Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival.J Neurooncol. 2017 Nov;135(2):391-402. doi: 10.1007/s11060-017-2587-5. Epub 2017 Jul 28. J Neurooncol. 2017. PMID: 28755324 Review.
-
Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[18F]fluoroethyl)-L-tyrosine (FET).Methods. 2017 Nov 1;130:124-134. doi: 10.1016/j.ymeth.2017.05.019. Epub 2017 May 24. Methods. 2017. PMID: 28552264 Review.
Cited by
-
5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma.Neurosurgery. 2019 Dec 1;85(6):E1020-E1029. doi: 10.1093/neuros/nyz199. Neurosurgery. 2019. PMID: 31215632 Free PMC article.
-
Static and dynamic 18F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status.Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):443-451. doi: 10.1007/s00259-017-3846-6. Epub 2017 Oct 17. Eur J Nucl Med Mol Imaging. 2018. PMID: 29043400
-
Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study.Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1458-1467. doi: 10.1007/s00259-019-04656-2. Epub 2020 Jan 9. Eur J Nucl Med Mol Imaging. 2020. PMID: 31919633 Free PMC article.
-
Semantic imaging features predict disease progression and survival in glioblastoma multiforme patients.Strahlenther Onkol. 2018 Jun;194(6):580-590. doi: 10.1007/s00066-018-1276-4. Epub 2018 Feb 13. Strahlenther Onkol. 2018. PMID: 29442128 English.
-
Combining multimodal imaging and treatment features improves machine learning-based prognostic assessment in patients with glioblastoma multiforme.Cancer Med. 2019 Jan;8(1):128-136. doi: 10.1002/cam4.1908. Epub 2018 Dec 18. Cancer Med. 2019. PMID: 30561851 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical